Aristopharma Ltd. has launched Triflo, a FDA approved ICS+LABA+LAMA combination consisting of Fluticasone Furoate, Vilanterol & Umeclidinium as Dry Powder Inhalation Capsule.
“Triflo Arocap”, a once-daily triple combination of ICS/LAMA/LABA consisting of Fluticasone, Umeclidinium & Vilanterol, the first and only once-daily, 3-in-1 treatment option, approved by USFDA to meet your patients’ necessities and conveniences.
• Truly Once-daily 3-in-1 medicine of Triflo Arocap works combinedly to control Asthma, COPD & ACO
• Triflo Arocap ensures excellent lung function improvement in both Asthma & COPD patients compared to LAMA/LABA or ICS/ LABA
Triflo Arocap combination is recommended & approved by various guidelines & regulatory agencies e.g., FDA, EMA, GINA, GOLD, BNF, etc.
Aristopharma Ltd. is one of the top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen.